Joseph Anderberg,Jeff Gray,Paul McPherson,Kevin Nakamura,James Patrick Kampf
申请号：
US14381532
公开号：
US20150010929A1
申请日:
2013.02.27
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of SPARC, Follistatin-related protein 1, Tumor necrosis factor receptor superfamily member 21, Growth arrest-specific protein 1, MHC class I polypeptide-related sequence A, Syndecan-1, and WNT1-inducible-signaling pathway protein 1 as diagnostic and prognostic biomarkers in renal injuries.
